Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · October 14, 2022

MRI to Assess Response After Neoadjuvant Chemotherapy in Breast Cancer Subtypes

NPJ breast cancer

 

Additional Info

NPJ breast cancer
MRI to assess response after neoadjuvant chemotherapy in breast cancer subtypes: a systematic review and meta-analysis
NPJ Breast Cancer 2022 Sep 19;8(1)107, LM Janssen, BM den Dekker, KGA Gilhuijs, PJ van Diest, E van der Wall, SG Elias

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading